YD Bio Limited Ordinary Shares
General ticker "YDES" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $191.2M (TTM average)
YD Bio Limited Ordinary Shares does not follow the US Stock Market performance with the rate: -21.1%.
Estimated limits based on current volatility of 3.3%: low 4.40$, high 4.73$
Short-term YDES quotes
Long-term YDES plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.60MM |
| Operating Expenses | $5.87MM |
| Operating Income | $-5.27MM |
| Non-Operating Income | $-3.04MM |
| R&D Expense | $1.60MM |
| Income(Loss) | $-8.31MM |
| Taxes | $-0.00MM |
| Profit(Loss)* | $-8.31MM |
| Stockholders Equity | $-2.86MM |
| Inventory | $1.88MM |
| Assets | $13.78MM |
| Operating Cash Flow | $-6.60MM |
| Capital expenditure | $1.44MM |
| Investing Cash Flow | $-1.44MM |
| Financing Cash Flow | $10.87MM |
| Earnings Per Share** | $-0.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.